Steve Atkinson

Steve Atkinson is an accomplished executive with extensive experience in the healthcare and medical device sectors. At Systagenix Wound Management, Steve served as CEO during a successful acquisition from Johnson & Johnson. Other notable positions include Managing Director for GE Healthcare's Sub-Acute Care in EMEA, Senior Vice President at Zeltiq Aesthetics, and CEO of INNOVO by Atlantic Therapeutics, where innovative therapies for urinary incontinence were developed. Steve has also held strategic advisory roles at Sutrue and Dreem, contributing to advancements in automated suturing and sleep assessment technology. Additionally, Steve's leadership extends to current roles as Non-Executive Director at SOAR Running and overseer at Healthy Networks, with a focus on AI development for lung diagnostics. Educational credentials include an advanced management program from Northwestern University's Kellogg School of Management and a BA (Hons) from Leeds Carnegie.